Literature DB >> 26592513

Regulation of PP2Cm expression by miRNA-204/211 and miRNA-22 in mouse and human cells.

Bang-fen Pan1, Chen Gao2, Shu-xun Ren2, Yi-bin Wang1,2, Hai-peng Sun1,2, Mei-yi Zhou1.   

Abstract

AIM: The mitochondrial targeted 2C-type serine/threonine protein phosphatase (PP2Cm) is encoded by the gene PPM1K and is highly conserved among vertebrates. PP2Cm plays a critical role in branched-chain amino acid catabolism and regulates cell survival. Its expression is dynamically regulated by the nutrient environment and pathological stresses. However, little is known about the molecular mechanism underlying the regulation of PPM1K gene expression. In this study, we aimed to reveal how PPM1K expression is affected by miRNA-mediated post-transcriptional regulation.
METHODS: Computational analysis based on conserved miRNA binding motifs was applied to predict the candidate miRNAs that potentially affect PPM1K expression. Dual-luciferase reporter assay was performed to verify the miRNAs' binding sites in the PPM1K gene and their influence on PPM1K 3'UTR activity. We further over-expressed the mimics of these miRNAs in human and mouse cells to examine whether miRNAs affected the mRNA level of PPM1K.
RESULTS: Computational analysis identified numerous miRNAs potentially targeting PPM1K. Luciferase reporter assays demonstrated that the 3'UTR of PPM1K gene contained the recognition sites of miR-204 and miR-211. Overexpression of these miRNAs in human and mouse cells diminished the 3'UTR activity and the endogenous mRNA level of PPM1K. However, the miR-22 binding site was found only in human and not mouse PPM1K 3'UTR. Accordingly, PPM1K 3'UTR activity was suppressed by miR-22 overexpression in human but not mouse cells.
CONCLUSION: These data suggest that different miRNAs contribute to the regulation of PP2Cm expression in a species-specific manner. miR-204 and miR-211 are efficient in both mouse and human cells, while miR-22 regulates PP2Cm expression only in human cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26592513      PMCID: PMC4816230          DOI: 10.1038/aps.2015.119

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  43 in total

Review 1.  Lessons from genetic disorders of branched-chain amino acid metabolism.

Authors:  David T Chuang; Jacinta L Chuang; R Max Wynn
Journal:  J Nutr       Date:  2006-01       Impact factor: 4.798

Review 2.  Branched-chain [corrected] amino acid metabolism: implications for establishing safe intakes.

Authors:  Susan M Hutson; Andrew J Sweatt; Kathryn F Lanoue
Journal:  J Nutr       Date:  2005-06       Impact factor: 4.798

Review 3.  Mechanisms responsible for regulation of branched-chain amino acid catabolism.

Authors:  Robert A Harris; Mandar Joshi; Nam Ho Jeoung
Journal:  Biochem Biophys Res Commun       Date:  2004-01-09       Impact factor: 3.575

4.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance.

Authors:  Christopher B Newgard; Jie An; James R Bain; Michael J Muehlbauer; Robert D Stevens; Lillian F Lien; Andrea M Haqq; Svati H Shah; Michelle Arlotto; Cris A Slentz; James Rochon; Dianne Gallup; Olga Ilkayeva; Brett R Wenner; William S Yancy; Howard Eisenson; Gerald Musante; Richard S Surwit; David S Millington; Mark D Butler; Laura P Svetkey
Journal:  Cell Metab       Date:  2009-04       Impact factor: 27.287

5.  A novel regulatory defect in the branched-chain α-keto acid dehydrogenase complex due to a mutation in the PPM1K gene causes a mild variant phenotype of maple syrup urine disease.

Authors:  Alfonso Oyarzabal; Mercedes Martínez-Pardo; Begoña Merinero; Rosa Navarrete; Lourdes R Desviat; Magdalena Ugarte; Pilar Rodríguez-Pombo
Journal:  Hum Mutat       Date:  2012-12-12       Impact factor: 4.878

6.  Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy.

Authors:  Gaia Novarino; Paul El-Fishawy; Hulya Kayserili; Nagwa A Meguid; Eric M Scott; Jana Schroth; Jennifer L Silhavy; Majdi Kara; Rehab O Khalil; Tawfeg Ben-Omran; A Gulhan Ercan-Sencicek; Adel F Hashish; Stephan J Sanders; Abha R Gupta; Hebatalla S Hashem; Dietrich Matern; Stacey Gabriel; Larry Sweetman; Yasmeen Rahimi; Robert A Harris; Matthew W State; Joseph G Gleeson
Journal:  Science       Date:  2012-09-06       Impact factor: 47.728

Review 7.  Neurological damage in MSUD: the role of oxidative stress.

Authors:  Angela Sitta; Graziela S Ribas; Caroline P Mescka; Alethéa G Barschak; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2013-11-13       Impact factor: 5.046

8.  The sufficient minimal set of miRNA seed types.

Authors:  Daniel C Ellwanger; Florian A Büttner; Hans-Werner Mewes; Volker Stümpflen
Journal:  Bioinformatics       Date:  2011-03-26       Impact factor: 6.937

9.  Role for miR-204 in human pulmonary arterial hypertension.

Authors:  Audrey Courboulin; Roxane Paulin; Nellie J Giguère; Nehmé Saksouk; Tanya Perreault; Jolyane Meloche; Eric R Paquet; Sabrina Biardel; Steeve Provencher; Jacques Côté; Martin J Simard; Sébastien Bonnet
Journal:  J Exp Med       Date:  2011-02-14       Impact factor: 14.307

10.  MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1.

Authors:  Hanwen Zhang; Qiuyu Wang; Qian Zhao; Wen Di
Journal:  J Ovarian Res       Date:  2013-11-26       Impact factor: 4.234

View more
  4 in total

1.  Transcriptome association analysis identifies miR-375 as a major determinant of variable acetaminophen glucuronidation by human liver.

Authors:  Ioannis Papageorgiou; Marina Freytsis; Michael H Court
Journal:  Biochem Pharmacol       Date:  2016-08-13       Impact factor: 5.858

2.  Oncolytic Reovirus (pelareorep) Induces Autophagy in KRAS-mutated Colorectal Cancer.

Authors:  Jeeshan Jiffry; Thongthai Thavornwatanayong; Sanjay Goel; Radhashree Maitra; Devika Rao; Elisha J Fogel; Durvanand Saytoo; Rishika Nahata; Hillary Guzik; Imran Chaudhary; Titto Augustine
Journal:  Clin Cancer Res       Date:  2020-11-09       Impact factor: 12.531

3.  A cerebrospinal fluid microRNA analysis: Progressive supranuclear palsy.

Authors:  Wakako Nonaka; Tadayuki Takata; Hisakazu Iwama; Satoshi Komatsubara; Hideki Kobara; Masaki Kamada; Kazushi Deguchi; Tetsuo Touge; Osamu Miyamoto; Takehiro Nakamura; Toshifumi Itano; Tsutomu Masaki
Journal:  Mol Med Rep       Date:  2022-01-18       Impact factor: 2.952

4.  Autophagy and Inflammasome Activation in Dilated Cardiomyopathy.

Authors:  Angela Caragnano; Aneta Aleksova; Michela Bulfoni; Celeste Cervellin; Irene Giulia Rolle; Claudia Veneziano; Arianna Barchiesi; Maria Chiara Mimmi; Carlo Vascotto; Nicoletta Finato; Sandro Sponga; Ugolino Livi; Miriam Isola; Carla Di Loreto; Rossana Bussani; Gianfranco Sinagra; Daniela Cesselli; Antonio Paolo Beltrami
Journal:  J Clin Med       Date:  2019-09-21       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.